Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00078
http://purl.obolibrary.org/obo/dinto_DB00078
|
|---|---|
| Preferred Name | ibritumomab |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | ibritumomab
|
|---|---|
| label | ibritumomab
|
| DBSynonym |
ig gamma-2a chain c region, membrane-bound form
radiolabeled murine anti-cd20
|
| ATCCode | V10XX02
|
| Definition | Indium conjugated murine IgG1 kappa monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes. Ibritumomab is produced in Chinese hamster ovary cells and is composed of two murine gamma 1 heavy chains of 445 amino acids each and two kappa light chains of 213 amino acids each.
|
| has pharmacological target | |
| type | |
| xref |
RxList:http://www.rxlist.com/cgi/generic3/zevalin.htm
Wikipedia:http://en.wikipedia.org/wiki/Ibritumomab
GenBank:J00470
UniProtKB:P01865
Drugs.com:http://www.drugs.com/cdi/ibritumomab-tiuxetan-with-indium-111.html
PharmGKB:PA164781375
See more
See less
|
| CASRN | 174722-31-7
|
| prefixIRI | obo2:dinto_DB00078
|
| related with |
See more
See less
|
| may interact with | |
| DBBrand | zevalin (idec pharmaceuticals)
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |